X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TEVA PHARMA
Dec-13
ALKEM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5892,675-   
Low Rs1,2322,324-   
Sales per share (Unadj.) Rs417.51,535.0-  
Earnings per share (Unadj.) Rs56.395.9-  
Cash flow per share (Unadj.) Rs64.7220.0-  
Dividends per share (Unadj.) Rs12.7083.94-  
Dividend yield (eoy) %0.93.4 26.8%  
Book value per share (Unadj.) Rs292.91,705.1-  
Shares outstanding (eoy) m119.57848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.6 207.5%   
Avg P/E ratio x25.126.1 96.1%  
P/CF ratio (eoy) x21.811.4 191.9%  
Price / Book Value ratio x4.81.5 328.5%  
Dividend payout %22.687.5 25.8%   
Avg Mkt Cap Rs m168,6532,119,254 8.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM28,962.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,809.3-  
INCOME DATA
Net Sales Rs m49,9151,301,721 3.8%  
Other income Rs m1,6450-   
Total revenues Rs m51,5611,301,721 4.0%   
Gross profit Rs m8,482356,477 2.4%  
Depreciation Rs m1,006105,219 1.0%   
Interest Rs m67125,568 2.6%   
Profit before tax Rs m8,451225,690 3.7%   
Minority Interest Rs m-1141,025 -11.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,153 0.0%   
Tax Rs m1,606-2,755 -58.3%   
Profit after tax Rs m6,73181,318 8.3%  
Gross profit margin %17.027.4 62.1%  
Effective tax rate %19.0-1.2 -1,556.5%   
Net profit margin %13.56.2 215.9%  
BALANCE SHEET DATA
Current assets Rs m27,062879,178 3.1%   
Current liabilities Rs m15,324766,717 2.0%   
Net working cap to sales %23.58.6 272.2%  
Current ratio x1.81.1 154.0%  
Inventory Days Days6791 73.2%  
Debtors Days Days4196 43.0%  
Net fixed assets Rs m12,610425,171 3.0%   
Share capital Rs m2393,204 7.5%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,0271,445,965 2.4%   
Long term debt Rs m1,212665,599 0.2%   
Total assets Rs m54,3872,974,850 1.8%  
Interest coverage x13.69.8 138.4%   
Debt to equity ratio x00.5 7.5%  
Sales to assets ratio x0.90.4 209.7%   
Return on assets %13.63.6 378.8%  
Return on equity %19.25.6 341.7%  
Return on capital %24.94.9 504.1%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,259207,427 3.5%  
From Investments Rs m1,864-73,500 -2.5%  
From Financial Activity Rs m-9,273-248,823 3.7%  
Net Cashflow Rs m-150-114,895 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.08 Rs / USD

Compare ALKEM LABORATORIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALKEM LABORATORIES With: ALEMBIC PHARMA  TTK HEALTHCARE  STRIDES SHASUN LTD  WYETH LTD  FRESENIUS KABI ONCO.  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 22, 2017 03:36 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - AUROBINDO PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS